JOINT FILING AGREEMENT
Exhibit 99.2
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated February 4, 2020 (including amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of CTI BioPharma Corp. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: February 4, 2020
BIOTECHNOLOGY VALUE FUND, L.P. | Biotechnology Value Trading Fund OS LP | |||
By: | BVF I GP LLC., its general partner | |||
By: | BVF Partners L.P., its investment manager | |||
By: | /s/ Xxxx X. Xxxxxxx | By: | BVF Inc., its general partner | |
Xxxx X. Xxxxxxx | ||||
Chief Executive Officer | By: | /s/ Xxxx X. Xxxxxxx | ||
Xxxx X. Xxxxxxx | ||||
President | ||||
BVF I GP LLC | ||||
By: | /s/ Xxxx X. Xxxxxxx | BVF GP HOLDINGS LLC | ||
Xxxx X. Xxxxxxx | ||||
Chief Executive Officer | By: | /s/ Xxxx X. Xxxxxxx | ||
Xxxx X. Xxxxxxx | ||||
Chief Executive Officer | ||||
BIOTECHNOLOGY VALUE FUND II, L.P. | ||||
By: | BVF II GP LLC its general partner | BVF PARTNERS L.P. | ||
By: | /s/ Xxxx X. Xxxxxxx | By: | BVF Inc., its general partner | |
Xxxx X. Xxxxxxx | ||||
Chief Executive Officer | By: | /s/ Xxxx X. Xxxxxxx | ||
Xxxx X. Xxxxxxx | ||||
President | ||||
BVF II GP LLC | ||||
By: | /s/ Xxxx X. Xxxxxxx | BVF INC. | ||
Xxxx X. Xxxxxxx | ||||
Chief Executive Officer | By: | /s/ Xxxx X. Xxxxxxx | ||
Xxxx X. Xxxxxxx | ||||
President | ||||
BVF PARTNERS OS LTD. | ||||
By: | BVF Partners L.P., its sole member | /s/ Xxxx X. Xxxxxxx | ||
By: | BVF Inc., its general partner | XXXX X. XXXXXXX | ||
By: | /s/ Xxxx X. Xxxxxxx | |||
Xxxx X. Xxxxxxx | /s/ Xxxxxxx X. Xxxxx | |||
President | XXXXXXX X. XXXXX |